Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Duration of protective effect from inhaled ipratropium bromide on methacholine airway hyperresponsiveness

Trial Profile

Duration of protective effect from inhaled ipratropium bromide on methacholine airway hyperresponsiveness

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 May 2009

At a glance

  • Drugs Ipratropium bromide (Primary)
  • Indications Asthma
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 01 May 2009 Results reported in Annals of Allergy, Asthma and Immunology.
    • 20 Jul 2008 Actual patient number (12) added as reported by ClinicalTrials.gov.
    • 20 Jul 2008 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top